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Abstract. Chronic expanding hematoma (CEH) is a rare 
disease that is usually present as a large solitary pulmonary 
nodule. CEHs are slow growing, but processes underlying 
their development remain unknown. The present study herein 
reports the case of a 76-year-old male patient with CEH and 
discusses a number of CEH cases published in the literature. 
The majority of these previously described patients were 
Asians. The CEH in the present case was not a success-
fully resected one, but the patient's clinical course provided 
information concerning the natural history of the disease. 
During the clinical course, the patient underwent several chest 
computed tomography scans. For the present case report, the 
doubling time and volume change of the mass was calculated, 
which revealed that the lesion had an inconstant growth rate 
and that its onset was between 8.2-11.0 years before the patient 
succumbed to this disease. Accumulation of knowledge about 
this rare disease will help to elucidate it further.
Introduction
Hematomas are masses of usually clotted blood that form in 
tissues, organs or body spaces as a result of a broken blood 
vessel (1-3). Among hematomas, chronic expanding hema-
tomas (CEHs) are rare (1-21). Chronic inflammation, invoked 
by hematoma, is thought to lead to the formation of a capsule 
around the hematoma, and new vessel growth in and around 
the capsule (22). Furthermore, the gradual formation of a 
hematoma accompanies leakage of blood from the new vessels, 
which increases permeability through a plasminogen activator 
that is precipitated in the clot (1). The majority of patients with 
CEH in the chest typically have a history of medical or surgical 
therapy for tuberculosis (2-14), although some develop CEH 
after thoracic surgery for non-tuberculous diseases (15-19) or 
blunt thoracic trauma (19-21). CEH was initially reported as a 
clinical entity in the 1980s, but the exact prevalence of CEH 
within populations and mortality rates are unknown because 
of its rarity. The symptoms of CEH differ depending on the 
site where CEH occurs, but similar symptoms accompanying 
the increase of CEH have been identified. When CEH occurs 
in the chest, dyspnea and chest wall masses occur due to an 
increase in the volume of the hematoma (22). In a recent 
review of the Japanese and English literature, only 91 patients 
with this disease have been described (22). According to the 
review, they had a broad age distribution; 70.3% of them were 
male, and lesions were predominantly on the trunk and lower 
extremities. The range of clinical latent periods was wide, 
ranging from one month to 57 years (1,23-26). A commonly 
used treatment method for CEH is complete excision, which 
yields the best clinical outcomes (26). The current report 
presents the natural history of a CEH that presented as a 
slow-growing mass, which was determined by calculating its 
doubling time and volume changes.
Case report
A 76-year-old man was referred to the University of 
Tsukuba-Mito Kyodo General Hospital (Mito, Japan) in March 
2013 because of dyspnea upon exertion, which had first become 
apparent 4 years before. A large mass with a maximum diam-
eter of 17x12 cm had been found on a chest X-ray nine years 
ago in a mass screening by the prefecture where the patient 
lived. This finding was followed up for seven years at a local 
clinic near the patient's address by chest X-ray, and the mass 
was slowly growing. However, the patient did not want further 
examination and treatment during this period. Thereafter, the 
patient visited the thoracic surgery department in University 
of Tsukuba Hospital (Tsukuba, Japan) in August 2013, but 
decided not to undergo surgical removal of the lesion. In addi-
tion, the patient had a 10 pack-years smoking history up to 
the age of 45, and reported that he had suffered a blunt chest 
trauma in a traffic accident 29 years before, but no medical 
record or imaging study of this was available.
On admission to the University of Tsukuba-Mito Kyodo 
General Hospital, respiratory sounds in the left lung were 
absent and heart sounds were audible in the right thorax. A 
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chest radiograph and computed tomography (CT) revealed a 
mass of inhomogeneous density, with focal calcification within 
the mass (Fig. 1A). A percutaneous biopsy was performed but 
the pathological diagnosis was not established because only 
necrotic tissue was present within the specimen. The patient 
was discharged, and he received oxygen therapy at home 
because he did not want any further invasive treatment, then 
his respiratory condition gradually deteriorated. Furthermore, 
the patient succumbed to respiratory failure two years after 
the initiation of home oxygen therapy and died in March 2015. 
Over the course of the patient's illness, he received seven chest 
CT scans. Fig. 1B reports the chest CT scan taken 9 years prior 
to patient mortality. Finally, an autopsy was performed and the 
final diagnosis of the mass was CEH.
With regard to the autopsy observations, grossly, a 29 cm, 
5.9 kg mass containing coagulative necrotic tissue occupied 
the entire left thoracic cavity (Fig. 2A). The wall of the lesion 
was well demarcated, strongly adherent and was expanding to 
the surrounding structures. In addition, the lesion was encased 
in a thick capsule (Fig. 2B), and there was no evidence of 
neoplasia. Fig. 3 shows the relationship between ‘volume of 
mass’ and ‘days prior to mortality’ using the results from CT 
scans taken over the course of the patient's disease.
The graph line, which was constructed by taking plots of the 
estimated volume of the lesion and analyzed with VINCENT 
v. 4.0 (Fujifilm Workstation, Tokyo, Japan), the time when the 
CEH began to develop was evaluated using the least-squares 
method (27). The estimation indicated that the onset time of 
CEH was 8.2-11.0 years before the patient mortality.
The doubling time of the disease (DTD) was calculated 
using the chest CT scans that were recorded 7 times during 
the clinical course. The DTD was calculated using a modi-
fication of the following Schwartz formula of exponential 
growth (28): DTD=(txlog2)/(3xlog (V2/V1)); where V1 and 
Figure 3. Change in the mass volume calculated and extrapolated.
Figure 2. (A) Mass, removed at autopsy, containing coagulative necrotic tissue occupied the entire left thoracic cavity. (B) The lesion was encased in a thick 
capsule, and the inside of the mass was composed of a hematoma with vascular organization.
Figure 1. (A) Chest CT scan at the admission to the University of Tsukuba-Mito Kyodo General Hospital showed a mass of inhomogeneous density (arrows) 
with focal calcification within the mass (triangles). (B) Chest CT scan taken 9 years before the patient's mortality. CT, computed tomography.
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V2 were the largest diameters on the CT scan measured 
at 2 different times, and t was the time interval between 2 
measurements. The DTD of the CEH in this patient is shown 
in Table I.
Discussion
CEH in the chest is a rare clinicopathological entity. The 
majority of patients with this disease have a history of medical 
or surgical therapy for tuberculosis (2-14), although some 
develop CEH after thoracic surgery for non-tuberculous 
diseases (15-18) or blunt thoracic trauma (19-21). The most 
common symptoms of CEH in the chest are dyspnea related 
to compression of the lung, and slowly growing chest wall 
mass (22). Although the possibility of being treated as another 
disease in countries outside Northeast Asia cannot be denied, 
almost of the patients previously reported to have CEH in 
the chest were Japanese (3-6,8,9,11-14) with some from other 
Northeast Asian countries (2,7,10). Radiologically, CEH in the 
chest appears as an intrathoracic mass in chest X-ray. Findings 
in chest CT scan consist of a heterogeneous mass with a wall 
of variable thickness that often contains peripheral areas of 
calcification (4). The pathogenesis of CEH is still unknown. 
According to a theory by Labadie and Glover, however, the 
self-perpetuating expanding process in CEH is due to the irri-
tant effects of blood and its breakdown products, which cause 
repeated episodes of bleeding from capillaries in the granula-
tion tissue (1). The range of clinical latent period in previous 
reports is wide, ranging from 1 month to 57 years (1,23-26).
In the present case, a surgical resection of the lesion 
could not be performed due to the patient's refusal to undergo 
surgery. As a result, the clinical course of the disease could 
be observed from the time of the first CT scan taken 9 years 
before his referral to the hospital. CEH may grow very slowly, 
however, the natural course of the disease has not been eluci-
dated, either for those with a prior history of tuberculosis or 
for those without it.
Currently, the natural history, pathogenesis and mecha-
nism of CEH are unknown. It is important to provide and 
accumulate knowledge on the increase in the size of the lesion 
and on its doubling time. The present study therefore showed 
the DTD (Table I) and the volume change of CEH. The estima-
tion indicated that the onset time of CEH was 8.2-11.0 years 
before the patient mortality. However, this onset time was not 
the same as that at which he said he had suffered a blunt chest 
trauma in a traffic accident (about 26 years before succumbing 
to the present disease). As no medical records or imaging were 
available, the difference cannot be explained but it is believed 
that this chest trauma had no direct association with the devel-
opment of CEH. The patient of the present study had no prior 
history of tuberculosis and a relatively short interval between 
the prior medical event and the development of CEH, which 
was consistent with the results of previous cases with no prior 
history of tuberculosis (2-14).
Therefore, the present study has reported a case of CEH. The 
patient did not undergo any surgical resection due to his refusal 
of surgery, but this case illustrated a natural course of CEH, 
which may provide clues towards clarifying the mechanism 
and etiology of CEH. Furthermore, accumulation of knowledge 
about this rare disease will help to elucidate it further.
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